Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05819138 · ClinicalTrials.gov registry record · Phase 3

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

A Phase 3 study of Diabetes Mellitus, Type 1, sponsored by University of Colorado, Denver.

Recruiting
Registry status
Phase 3
Development phase
60
Enrollment target
2
Study locations

NCT05819138 is a Phase 3 study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 60 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05819138, a Phase 3 study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
Phase 3
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose control and BMI in adults with type 2 diabetes. This study aims to look at how well the medication works in people with type 1 diabetes. Semaglutide is not approved by the FDA to be used in this way. These procedures are considered to be experimental.

Conditions Studied

Diabetes Mellitus, Type 1

Interventions

  • DRUG Placebo
  • DRUG Semaglutide Pen Injector

Study Locations (2)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Washington

  • University of Washington Medicine Diabetes Institute (UWMDI) - Seattle

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-06-21
Est. Completion 2027-12-01
Phase Phase 3

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05819138

The ClinicalTrials.gov registry entry for NCT05819138 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (95% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05819138 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Washington.

Frequently Asked Questions

What is clinical trial NCT05819138 about?

NCT05819138 is a clinical study titled "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes". This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose ...

What is the current status of trial NCT05819138?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2023-06-21. Estimated completion is 2027-12-01.

What conditions does trial NCT05819138 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

What interventions are being tested in trial NCT05819138?

The interventions under investigation include: Placebo (DRUG), Semaglutide Pen Injector (DRUG).

Who is sponsoring clinical trial NCT05819138?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05819138 being conducted?

This trial has 2 study locations across Colorado, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Diabetes Mellitus, Type 1

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.